Yahoo
NYSE American - Delayed Quote USD

Lineage Cell Therapeutics, Inc. (LCTX)

1.0000 -0.0300 (-2.91%)
At close: October 30 at 4:00:00 PM EDT
1.0169 +0.0169 (+1.69%)
After hours: October 30 at 5:02:01 PM EDT
Trade LCTX on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
13,083
14,556
9,499
8,945
14,703
Cost of Revenue
71
146
334
671
728
Gross Profit
13,012
14,410
9,165
8,274
13,975
Operating Expense
39,862
36,189
30,643
33,007
36,495
Operating Income
-26,850
-21,779
-21,478
-24,733
-22,520
Net Non Operating Interest Income Expense
1,542
1,691
1,715
1,629
829
Other Income Expense
-12,085
-48,567
1,173
-178
-4,121
Pretax Income
-37,385
-68,647
-18,582
-23,282
-25,812
Tax Provision
--
-5,280
0
-1,803
541
Net Income Common Stockholders
-32,260
-63,533
-18,609
-21,486
-26,273
Diluted NI Available to Com Stockholders
-32,260
-63,533
-18,609
-21,486
-26,273
Basic EPS
-0.14
-0.28
-0.09
-0.12
-0.15
Diluted EPS
-0.19
-0.28
-0.09
-0.12
-0.15
Basic Average Shares
240,148
230,116
200,193
172,663
169,792
Diluted Average Shares
247,272
230,116
200,193
172,663
169,792
Total Operating Income as Reported
-26,850
-36,619
-21,478
-24,733
-22,520
Total Expenses
39,933
36,335
30,977
33,678
37,223
Net Income from Continuing & Discontinued Operation
-32,260
-63,533
-18,609
-21,486
-26,273
Normalized Income
-20,165
-18,846.8690
-20,452
-20,823.6000
-24,717.4900
Interest Income
1,542
1,691
1,715
1,629
829
Net Interest Income
1,542
1,691
1,715
1,629
829
EBIT
-26,850
-21,779
-21,478
-24,733
-22,520
EBITDA
-26,111
-21,080
-20,869
-24,041
-21,793
Reconciled Cost of Revenue
71
146
334
671
728
Reconciled Depreciation
739
699
609
692
727
Net Income from Continuing Operation Net Minority Interest
-32,260
-63,533
-18,609
-21,486
-26,273
Total Unusual Items Excluding Goodwill
-12,095
-48,435
1,843
-720
-1,969
Total Unusual Items
-12,095
-48,435
1,843
-720
-1,969
Normalized EBITDA
-14,016
27,355
-22,712
-23,321
-19,824
Tax Rate for Calcs
0
0.0001
0
0.0001
0.0002
Tax Effect of Unusual Items
0
-3,748.8690
0
-57.6000
-413.4900
12/31/2022 - 3/5/1992

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: